Publication

Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could also be key for 40 million people living with HIV around the world who need better options for treatment. It’s not a cure or a vaccine, but it could be a game-changer if made accessible to all who could benefit. Read press release More on lenacapavir: UNAIDS welcomes the announcement of new deals to make new HIV prevention medicines available and affordable for people in need | UNAIDS welcomes US announcement to expand access to medicine to prevent HIV and urges greater global ambition to reach all in need | UNAIDS calls on leaders at Davos to commit to rapid global access to revolutionary new long-acting HIV medicines | A shot at ending AIDS — How new long-acting medicines could revolutionize the HIV response